Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
Health care industry
Marty Makary resigns as FDA commissioner following industry and White House backlash
Food and Drug Administration Commissioner Marty Makary speaks during an announcement at the Department of Health and Human Services on...
MV Hondius hantavirus outbreak: A luxury expedition cruise boom and new world of remote travel risks
Remote expedition cruises to places like Antarctica and the Arctic are booming as affluent travelers increasingly seek out isolated, experience-driven...
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Whoop fitness wearable.Courtesy: WhoopWearable fitness tracker Whoop announced on Friday it will introduce in-app access to on-demand licensed clinicians for...
Wearable patches: How Barrière is trying to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health and wellness.Along...
CVS blows past estimates, hikes outlook as insurance business outperformsÂ
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026.Jeenah Moon...
FDA commissioner defends agency's drug approval decisions after wave of backlash
U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday after months of pressure...
Danco Laboratories seeks Supreme Court stay of ruling pausing mail-order access to abortion drugs
An abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on...
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary...
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook by...
Spotify teams up with Peloton to launch global fitness content hub
Spotify is increasing its push beyond music and podcasts as the company on Monday announced a new fitness category partnership...
FDA fast-tracks psychedelic drug research following Trump executive order
FILE PHOTO: Psilocybin or "magic mushrooms" are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA)...
Amazon launches GLP-1 weight loss program, promising'fast, convenient' access
Amazon GLP-1 treatmentSource: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program...
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.Lilly...
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Piotr Swat | Lightrocket | Getty ImagesAs its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding...
Trump nominates Erica Schwartz as CDC director
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight "the right way," Jane Zuckerman realized that "putting in the work just wasn't...
Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers
Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for...
FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based...
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025.Antranik Tavitian |...
